Published in Clin Neuropharmacol on April 02, 2008
Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology (2011) 1.42
Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol (2012) 0.99
Diagnosis and management of essential tremor and dystonic tremor. Ther Adv Neurol Disord (2009) 0.87
The GABA Hypothesis in Essential Tremor: Lights and Shadows. Tremor Other Hyperkinet Mov (N Y) (2014) 0.86
Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management. Curr Neuropharmacol (2012) 0.86
Overview of essential tremor. Neuropsychiatr Dis Treat (2010) 0.85
Use of antiepileptic drugs for hyperkinetic movement disorders. Curr Neuropharmacol (2010) 0.83
The treatment of tremor. Neurotherapeutics (2014) 0.82
Pharmacotherapy of essential tremor. J Cent Nerv Syst Dis (2013) 0.81
Topiramate and cognitive impairment: evidence and clinical implications. Ther Adv Drug Saf (2012) 0.80
Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2015) 0.75
Pharmacologic management of essential tremor. Can Fam Physician (2010) 0.75
A high-density microsatellite consensus map for bread wheat (Triticum aestivum L.). Theor Appl Genet (2004) 4.94
Development and mapping of SSR markers for maize. Plant Mol Biol (2002) 2.83
Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation (2013) 2.53
Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg (2006) 2.02
A web-based system for home monitoring of patients with Parkinson's disease using wearable sensors. IEEE Trans Biomed Eng (2010) 1.65
Toward positional cloning of Vgt1, a QTL controlling the transition from the vegetative to the reproductive phase in maize. Plant Mol Biol (2002) 1.49
Tardive dyskinesia due to aripiprazole: report of 2 cases. J Clin Psychopharmacol (2009) 1.45
The transcript composition of egg cells changes significantly following fertilization in wheat (Triticum aestivum L.). Plant J (2005) 1.38
Home monitoring of patients with Parkinson's disease via wearable technology and a web-based application. Conf Proc IEEE Eng Med Biol Soc (2010) 1.17
Reliability of a new scale for essential tremor. Mov Disord (2012) 1.17
High-throughput mutational analysis of TOR1A in primary dystonia. BMC Med Genet (2009) 1.14
The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov Disord (2011) 1.04
Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord (2007) 1.04
Deep brain stimulation effects on gait variability in Parkinson's disease. Mov Disord (2009) 1.00
Femtosecond phacoemulsification: the business and the medicine. Curr Opin Ophthalmol (2012) 0.94
Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord (2012) 0.94
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease. J Clin Pharmacol (2009) 0.89
Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it? Parkinsonism Relat Disord (2013) 0.89
Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients. Mov Disord (2004) 0.89
Anterior capsulotomy with an ultrashort-pulse laser. J Cataract Refract Surg (2011) 0.89
Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's disease. Neuromodulation (2011) 0.88
Treatment of dystonia. Expert Rev Neurother (2006) 0.88
Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis. Int J Geriatr Psychiatry (2007) 0.86
Nonlinear sensory cortex response to simultaneous tactile stimuli in writer's cramp. Mov Disord (2002) 0.86
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics (2003) 0.84
Case 3. Positron emission tomography-computed tomography diagnosis of metastatic melanoma with intussusception. J Clin Oncol (2004) 0.82
Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment. Clin Neurophysiol (2010) 0.81
Switching from donepezil or rivastigmine to galantamine in clinical practice. J Am Geriatr Soc (2004) 0.80
Early brain abscess: A rare complication of deep brain stimulation. Mov Disord (2009) 0.79
End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation. Mov Disord (2006) 0.78
New tools for single nucleotide polymorphism (SNP) discovery and analysis accelerating plant biotechnology. Plant Biotechnol J (2009) 0.78
Beating a dead horse: dopamine and Parkinson disease. Neurology (2008) 0.77
Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet (2010) 0.76
Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant. Mov Disord (2013) 0.76
Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders. Parkinsonism Relat Disord (2012) 0.76
Does subthalamotomy have a place in the treatment of Parkinson's disease? J Neurol Neurosurg Psychiatry (2009) 0.76
Deep-brain stimulation for dystonia: new twists in assessment. Lancet Neurol (2007) 0.75
Palmaris brevis spasm: An occupational syndrome. Neurology (2004) 0.75
Proposed new definition of cerebral palsy does not solve any of the problems of existing definitions. Dev Med Child Neurol (2006) 0.75
Initial treatment of Parkinson's disease: an update. Curr Treat Options Neurol (2013) 0.75
Diabetic gastroparesis. N Engl J Med (2007) 0.75
The current state and needs of north american movement disorders fellowship programs. Parkinsons Dis (2013) 0.75
Reply to letter regarding article, "Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010". Circulation (2014) 0.75
Ultrashort-pulse lasers treating the crystalline lens: will they cause vision-threatening cataract? (An American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2012) 0.75
Sustained dyskinesias following elective cessation and reactivation of chronic subthalamic nucleus deep brain stimulation for a surgical procedure. Neuromodulation (2011) 0.75
An open-label trial of levetiracetam for treatment of cervical dystonia. Mov Disord (2006) 0.75
Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet (2010) 0.75
Evidence-based practice. Nurse Res (2002) 0.75
Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet (2010) 0.75
Sternutatory reflex induced by periocular needle insertion in patients receiving chronic botulinum toxin injections. Parkinsonism Relat Disord (2013) 0.75
Welcome to the first issue of the seventh volume of the Plant Biotechnology Journal.. Plant Biotechnol J (2009) 0.75
Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center. Neurodegener Dis (2016) 0.75
Bag valve mask failure during HEMS intubated stretcher winch. Air Med J (2012) 0.75
Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved? Mov Disord (2013) 0.75
Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet (2010) 0.75
Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. Hum Genet (2010) 0.75